Table 1. AF treatment patient characteristics (VKA: VKA Group—NOAC: NOAC Group).

Group	VKA	NOAC	Switch patients on VKA+NOAC
N of patients	1,355	577	239
Age, yrs
Mean (SD)	75.9 (8.6)	77.3 (9.2)	73.4 (8.1)
Sex
Male, N	659	272	128
Male, %	48.6%	47.1%	53.6%
CHA2DS2-VASc, score
Mean (SD)	3.1 (1.3)	3.1 (1.3)	2.9 (1.3)
Previous TIA-Stroke
N	36	36	7
%	2.7%	6.2%	2.9%
P-value¥	-	0.0001*	0.8108

¥ Pair-wise P-value for comparison vs. VKA

*Statistically significant i.e. p<0,05